https://minervax.fabrikstaging.com/mvx0006-phase-i/ 2024-03-05T09:32:42+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2022/02/Clinical-Trials.png https://minervax.fabrikstaging.com/minervax-raises-eur-54m-in-upsized-financing-to-advance-the-development-of-its-maternal-vaccine-against-group-b-streptococcus/ 2023-10-11T07:02:11+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/minervax-announces-completion-of-enrolment-in-phase-1-clinical-vaccine-trial-older-adults/ 2023-06-27T07:31:36+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/minervax-commences-first-phase-1-clinical-study-of-novel-gbs-vaccine-in-older-adults/ 2023-04-17T07:27:48+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/mvx0004-phase-ii/ 2023-04-03T16:10:36+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2022/02/Clinical-Trials.png https://minervax.fabrikstaging.com/minervax-appoints-lidia-oostvogels-as-chief-medical-officer/ 2023-01-05T08:12:02+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/minervax-announces-72m-eur-financing-to-advance-development-of-novel-vaccine-against-group-b-streptococcus/ 2022-12-15T08:00:17+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/minervax-announces-that-ema-has-awarded-prime-status/ 2022-09-20T10:47:04+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/minervax-provides-clinical-update-on-its-maternal-gbs-vaccine/ 2022-02-14T11:08:56+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/mvx0003-phase-i/ 2022-02-14T10:51:40+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2022/02/Clinical-Trials.png https://minervax.fabrikstaging.com/mvx0005-phase-ii/ 2022-02-14T10:51:20+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2022/02/Clinical-Trials.png https://minervax.fabrikstaging.com/mvx0002-phase-i/ 2022-02-14T10:51:03+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2022/02/Clinical-Trials.png https://minervax.fabrikstaging.com/mvx13211-phase-i/ 2022-02-14T10:50:34+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2022/02/Clinical-Trials.png https://minervax.fabrikstaging.com/fp7-grant/ 2022-02-03T11:05:56+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/minervax-provides-clinical-and-leadership-update/ 2021-10-07T07:38:41+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/minervax-announces-completion-of-474-meur-financing/ 2021-10-06T16:00:02+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/minervax-announces-investment-of-44-meur/ 2021-07-30T10:54:43+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/equity-and-loan-financing/ 2021-07-30T10:51:46+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/initiation-of-phase-i-clinical-trial/ 2021-07-30T10:51:34+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/participation-bill-melinda-gates-foundation-grant/ 2021-03-13T17:17:02+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/News.png https://minervax.fabrikstaging.com/initiation-of-phase-i-part-b/ 2021-03-13T17:16:47+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/News.png https://minervax.fabrikstaging.com/innovation-foundation-grant/ 2021-03-13T17:16:31+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/News.png https://minervax.fabrikstaging.com/equity-financing/ 2021-03-13T17:16:13+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/News.png https://minervax.fabrikstaging.com/completion-of-enrollment-of-phase-i-part-b/ 2021-03-13T17:15:46+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/News.png https://minervax.fabrikstaging.com/primary-endpoint-data-from-phase-i-part-b/ 2021-03-13T17:15:30+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/News.png https://minervax.fabrikstaging.com/innovation-foundation-grant/ 2021-03-13T17:15:12+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/News.png https://minervax.fabrikstaging.com/minervax-announces-results-from-phase-i-clinical-trial/ 2021-03-13T17:14:54+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/News.png https://minervax.fabrikstaging.com/eurostar-grant/ 2021-02-18T14:30:50+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/technology-foundation-grant/ 2021-02-18T14:29:24+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png https://minervax.fabrikstaging.com/danish-government-grant/ 2021-02-18T14:27:39+00:00 https://minervax.fabrikstaging.com/wp-content/uploads/2021/02/Press-Release.png